NextCure signs up to $745 million deal with China's Simcere to develop cancer drug
NextCure said it will gain global rights to the experimental therapy, SIM0505, in all regions except Greater China, where Simcere Zaiming will retain control.
Zaiming is eligible to receive payments throughout the potential development phases, including upfront payment and other milestones up to $745 million, as well as tiered royalties up to double digits on net sales outside China, NextCure added.
Simcere's SIM0505 belongs to a class of drugs known as antibody-drug conjugates (ADCs), which are more targeted than conventional chemotherapy.
These therapies, also known as 'guided missiles', use antibodies to deliver toxic drugs directly to cancer cells, helping to destroy the tumor while leaving healthy cells unharmed.
U.S. drugmakers have been licensing drugs from China for potential new medicines at an accelerating pace, as they look to rebuild pipelines of future products while facing a patent cliff for the older drugs.
The experimental cancer drug is currently being tested in an early-stage trial in China. Initial data from the trial is expected in the first half of next year.
The company expects to begin studying the drug in the U.S. in the third quarter of 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Finextra
20 minutes ago
- Finextra
Ryt Bank selects Provenir for AI risk decisioning
Provenir, a global leader in AI risk decisioning software, today announced it has partnered with Ryt Bank – The World's First AI-Powered Bank – to embolden the company's innovation and mission to deliver banking done right with speed, simplicity, and innovation. 0 Ryt Bank has selected the Provenir AI Decisioning Platform to power faster credit decisions and more personalized customer offers for its consumer lending products. As a newly licensed digital bank, Ryt Bank aimed to rapidly launch a consumer lending product that aligns with its AI-first approach. The challenge was to implement a decisioning infrastructure capable of delivering instant, personalized loan approvals while ensuring compliance with regulatory standards and risk management best practices. Ryt Bank selected Provenir's AI Decisioning Platform to support real-time credit risk assessment for instant loan approvals, and for its ability to surface data insights for personalized loan offers based on AI-driven customer profiling. Provenir will also play a crucial role in automating compliance checks to meet regulatory requirements while providing continuous learning models to adapt to changing market dynamics. Finally, Provenir will support fast, accurate decisions to elevate the customer experience, supporting Ryt Bank's mission to deliver smarter, faster finance and create meaningful impact for all Malaysians. 'Ryt Bank is taking digital banking to a new level with its AI-first approach and we are excited to be a part of its journey,' said Kavinesswaran Karthigasan, Head of APAC, Provenir. 'Our AI Decisioning Platform will provide the foundation for Ryt Bank to help reach its business goals via AI-driven decisioning that meets customer expectations for near instant approvals and highly personalized digital interactions.'
Reuters
21 minutes ago
- Reuters
China's Vice Premier He to hold US trade talks in Sweden
BEIJING, July 23 (Reuters) - China's Vice Premier He Lifeng will visit Sweden from July 27-30 to hold economic and trade talks with U.S. officials, the Chinese commerce ministry said on Wednesday.
Reuters
21 minutes ago
- Reuters
Australia's WiseTech to cut some jobs in AI-driven efficiency push
July 23 (Reuters) - Australia's WiseTech Global ( opens new tab confirmed on Wednesday it was cutting some roles as part of a workforce review to focus on "maximizing efficiency via automation and use of artificial intelligence". The software firm did not specify the number of jobs to be impacted in an emailed response to a Reuters query. The Australian Financial Review reported earlier, opens new tab in the day that the Sydney-headquartered logistics software provider has told employees it is increasing the use of AI across the business as part of a broad restructure, citing an email from WiseTech's chief of staff, Zubin Appoo. WiseTech, known for its flagship CargoWise platform, has a team of around 3,500 people across 38 countries, as of June 30, 2024, according to its 2024 annual report. A spokesperson said the firm is "supporting all impacted team members through this transition, including access to professional outplacement services." Wisetech's move mirrors broader industry trends, with technology companies worldwide reducing headcount to fund heavy investments in AI infrastructure. Earlier this month, Microsoft (MSFT.O), opens new tab announced plans to lay off nearly 4% of its workforce, while big tech peers including Amazon (AMZN.O), opens new tab, Facebook parent Meta (META.O), opens new tab and Alphabet's (GOOGL.O), opens new tab Google have all trimmed their labour forces in recent years.
